Back to search
FDAFDA · Food and drugs·Recall number D-097-2013

CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.

Published December 26, 2012 · Recall initiated: September 27, 2012

Summary

FDA records drug Class III recall D-097-2013, published December 26, 2012 and initiated September 27, 2012. Recalling firm: Genentech, Inc.; Status: Terminated; Reported quantity: 1128 bottles; Lot: Lot #: a) M1365B01, Exp 04/15; b) M1365, Exp 04/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Short Fill: some bottles contained less than 120-count per labeled claim.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Genentech, Inc.
Distributor
Nationwide
Lot
Lot #: a) M1365B01, Exp 04/15; b) M1365, Exp 04/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080. recalled?

Yes. FDA published recall D-097-2013 on December 26, 2012. Reported hazard: Short Fill: some bottles contained less than 120-count per labeled claim.

What should I do if I have this product?

Voluntary: Firm initiated · Letter